Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

Ultromics, Ltd.

US

Last updated May 23, 2026

What Ultromics, Ltd. makes

Ultromics, Ltd. develops application software for cardiac mapping, ultrasound imaging, and radiology DICOM processing. Their products include versions of EchoGo, designed for cardiac ultrasound analysis, and EchoGo Core and Pro, tailored for specific diagnostic workflows in echocardiography.

The company’s software portfolio is classified as Class II under FDA regulations and is listed via 510(k) and UDI submissions. These devices are authorised for use in the United States, where Ultromics, Ltd. is based.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does Ultromics, Ltd. manufacture or develop?

Ultromics, Ltd. specializes in developing application software for medical imaging and diagnostics. Their primary focus is on software designed for cardiac mapping, ultrasound imaging (specifically echocardiography), and radiology DICOM image processing. Examples include multiple versions of EchoGo, which are tailored for cardiac ultrasound analysis, as well as EchoGo Core and EchoGo Pro, which cater to specific diagnostic workflows in echocardiography.

Where is Ultromics, Ltd. based, and where are their devices authorised for use?

Ultromics, Ltd. is based in the United States. Their devices are authorised for use in the U.S., where they undergo regulatory processes such as 510(k) submissions and Unique Device Identification (UDI) listings to comply with FDA requirements.

Which regulatory registries or databases list Ultromics, Ltd.’s devices?

Ultromics, Ltd.’s devices are listed in the FDA’s 510(k) premarket notification registry and the UDI (Unique Device Identification) database. These registries are used to track and authorise medical devices in the United States, ensuring compliance with regulatory standards.

How are Ultromics, Ltd.’s devices classified under FDA regulations?

Ultromics, Ltd.’s devices fall under Class II classification according to FDA regulations. This classification applies to software applications that modify or enhance the performance of existing medical devices, such as their cardiac mapping and ultrasound imaging software, which require special controls to ensure safety and effectiveness without needing the stringent scrutiny of Class III devices.

What is the primary purpose of the software developed by Ultromics, Ltd.?

The primary purpose of Ultromics, Ltd.’s software is to enhance diagnostic workflows in cardiology and radiology. Their EchoGo and related applications are designed to streamline ultrasound imaging analysis, particularly in echocardiography, by providing advanced tools for cardiac mapping and DICOM image processing. This helps clinicians improve accuracy, efficiency, and decision-making in patient care.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
US
Address
—
Website
—
LinkedIn
—
Facebook
—
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
—
DUNS Number
—

Catalogue (12)

DeviceModel / ReferenceRegistriesClassStatus
EchoGo Core
FDA UDI
Class IIActive
EchoGo Heart Failure 2.0
FDA UDI
Class IIActive
EchoGo Core 2.0
FDA UDI
Class IIActive
EchoGo Amyloidosis 1.0
FDA UDI
Class IIActive
EchoGo Heart Failure 1.0
FDA UDI
Class IIActive
EchoGo Pro
FDA UDI
Class IIActive
EchoGo Core (2.0) K213275
FDA 510(k)
Class IIActive
EchoGo Amyloidosis (1.0) K240860
FDA 510(k)
Class IIActive
EchoGo Heart Failure K222463
FDA 510(k)
Class IIActive
EchoGo Core K191171
FDA 510(k)
Class IIActive
EchoGo Heart Failure (2.0) K240013
FDA 510(k)
Class IIActive
EchoGo Pro K201555
FDA 510(k)
Class IIActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Establishments (1)

Establishments registered with the FDA under this company group, matched by name.

  • Ultromics, Ltd. Oxford Oxfordshire · GB FEI 3016585383